Beth Alley has over 20 years of experience within the biopharmaceutical industry in regulatory affairs, commercial strategy, and medical writing throughout all phases of drug development. Her primary areas of focus have been in the development of biologics for the treatment of autoimmune, inflammatory, and infectious diseases.
Current role